THE ROLE OF NANOTECHNOLOGY IN TARGETED DRUG DELIVERY SYSTEMS

Authors

  • Dr. Ayesha Khan Department of Pharmaceutical Sciences, University of Lahore, Pakistan Author
  • Dr. Muhammad Ali Institute of Biomedical Sciences, University of Punjab, Lahore, Pakistan Author
  • Prof. Ellen Parkes Department of Chemistry, University of Oxford, UK Author
  • Dr. Michael Booth Department of Bioengineering, University College London, UK Author

DOI:

https://doi.org/10.71465/jhmri53

Keywords:

Nanotechnology, Targeted Drug Delivery, Nanocarriers, Drug Efficacy, Biocompatibility, Cancer Therapy

Abstract

Nanotechnology has revolutionized the field of drug delivery by enabling the development of systems that can deliver therapeutic agents directly to targeted sites in the body, thereby enhancing efficacy and minimizing side effects. This article reviews the role of nanotechnology in targeted drug delivery systems, focusing on the mechanisms, types of nanocarriers, and recent advancements in the field. The integration of nanotechnology with targeted delivery strategies has shown promise in treating various diseases, including cancer, by improving drug solubility, stability, and bioavailability. However, challenges such as biocompatibility, toxicity, and regulatory issues remain. Future research is essential to address these challenges and translate nanotechnology-based drug delivery systems into clinical practice.

References

Ahmad, N. R. (2026). AI-enabled public governance in developing states: Service delivery gains, accountability risks, and a practical risk-based regulatory model. Lex Localis - Journal of Local Self-Government, 24(S1), 99–117. https://doi.org/10.52152/wja5db40

image

Published

2023-03-31

Issue

Vol. 1 No. 1 (2023): Journal of Health, Medical Research and Innovations

Section

Articles

License

Copyright (c) 2023 Dr. Ayesha Khan, Dr. Muhammad Ali, Prof. Ellen Parkes, Dr. Michael Booth (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

All articles published in the Journal of Health, Medical Research and Innovations are distributed under an open access license. Authors retain copyright and grant the journal the right of first publication. The published content can be freely accessed, shared, and reused for non-commercial purposes, provided proper citation is maintained and the original work is not altered.